In the latter context, IGF-1 serves as an important growth stimulus for myeloma cells through its actions on the IGF-1 receptor (CD221) [80], a tyrosine kinase-linked activator of the PI3K/Akt pathway, which serves as a primary regulator of myeloma cell proliferation and apoptosis. Here, IGF1 is linked to plasma cell myeloma.